- Home
- SCKT vs COEP Comparison
SCKT vs COEP Comparison
Compare SCKT & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCKT
- COEP
- Stock Information
- Founded
- SCKT 1992
- COEP 2017
- Country
- SCKT United States
- COEP United States
- Employees
- SCKT N/A
- COEP N/A
- Industry
- SCKT Computer Manufacturing
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SCKT Technology
- COEP Health Care
- Exchange
- SCKT Nasdaq
- COEP Nasdaq
- Market Cap
- SCKT 9.0M
- COEP 8.1M
- IPO Year
- SCKT 1995
- COEP N/A
- Fundamental
- Price
- SCKT $1.29
- COEP $0.21
- Analyst Decision
- SCKT
- COEP
- Analyst Count
- SCKT 0
- COEP 0
- Target Price
- SCKT N/A
- COEP N/A
- AVG Volume (30 Days)
- SCKT 39.4K
- COEP 282.8K
- Earning Date
- SCKT 10-24-2024
- COEP 11-13-2024
- Dividend Yield
- SCKT N/A
- COEP N/A
- EPS Growth
- SCKT N/A
- COEP N/A
- EPS
- SCKT N/A
- COEP N/A
- Revenue
- SCKT $18,330,593.00
- COEP N/A
- Revenue This Year
- SCKT $10.78
- COEP N/A
- Revenue Next Year
- SCKT $8.00
- COEP N/A
- P/E Ratio
- SCKT N/A
- COEP N/A
- Revenue Growth
- SCKT 2.95
- COEP N/A
- 52 Week Low
- SCKT $0.91
- COEP $0.15
- 52 Week High
- SCKT $1.53
- COEP $1.33
- Technical
- Relative Strength Index (RSI)
- SCKT 59.99
- COEP 50.31
- Support Level
- SCKT $1.24
- COEP $0.19
- Resistance Level
- SCKT $1.43
- COEP $0.22
- Average True Range (ATR)
- SCKT 0.08
- COEP 0.02
- MACD
- SCKT 0.02
- COEP -0.00
- Stochastic Oscillator
- SCKT 70.45
- COEP 46.15
About SCKT Socket Mobile Inc.
Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, out of which the majority of the revenue is generated from the United States.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.